Key facts
- This page summarizes Bertolini Mark T.'s Form 4 filing for Oscar Health, Inc. (OSCR).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 07 Apr 2025, 16:26.
Bertolini Mark T. - 03 Apr 2025 Form 4 Insider Report for Oscar Health, Inc. (OSCR)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- OSCR
- Reported as of
- 03 Apr 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 07 Apr 2025, 16:26:37 UTC
- Prior SEC filing
- 20 Mar 2025
- Next SEC filing
- 04 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Melissa Curtin, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Bertolini Mark T. filed Form 4 for Oscar Health, Inc. (OSCR) on 07 Apr 2025.
Change
- Previous filing in this sequence was filed on 20 Mar 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OSCR
transaction
Class A Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +955,556
- Change %
- +50%
- Price
- $0.000000
- Shares after
- 2,866,666
- Date
- 03 Apr 2025
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
OSCR
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -955,556
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 03 Apr 2025
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 955,556
- Exercise price
- Footnotes
- F2, F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Represents shares issued upon the vesting of restricted stock units previously reported in Table II.
Footnote F2
Amount reflects that 955,555 shares to be issued upon the vesting of restricted stock units and that were previously reported on Table II are now reported on Table I.
Footnote F3
Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
Footnote F4
The restricted stock units vest in three equal annual installments beginning on April 3, 2024, subject to the Reporting Person's continued employment or service as the Chief Executive Officer or as a member of the Board of Directors through the applicable vesting date.